News | July 29, 2020
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital
Read More
Press Release | July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Read More
News | July 23, 2020
Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri
Read More
Press Release | July 16, 2020
Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner
Read More
Press Release | July 15, 2020
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
Read More
Press Release | July 9, 2020
ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer
Read More
Press Release | July 9, 2020
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Read More
Press Release | July 8, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
Read More
News | July 6, 2020
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Read More
Press Release | July 6, 2020
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
Read More
Press Release | June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Read More
Press Release | June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Read More
News | June 3, 2020
Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline
Read More
Press Release | May 28, 2020
Palvella Therapeutics Completes $45 Million Series C Financing
Read More
Press Release | May 26, 2020
Freenome Announces Initiation of the PREEMPT CRC Clinical Trial for the Early Detection and Prevention of Colorectal Cancer Using a Multiomics Blood Test
Read More
Press Release | May 19, 2020
HalioDx to Characterize the Immune Contexture of Patients Enrolled in ImCheck’s EVICTION Phase 1/2 Clinical Trial
Read More
Press Release | May 15, 2020
New Data from Carisma Therapeutics Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes
Read More
Press Release | May 15, 2020
Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I
Read More
News | May 12, 2020
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Read More
News | March 31, 2020
Latest Penn biotech spinout taking on cancer raises $1.6M from investors
Read More
